Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy has demonstrated a solid financial performance, with commercial pricing increasing sequentially by 2.2%, suggesting effective pricing strategies that enhance revenue potential. Additionally, the company's Industrial Injury Prevention (IIP) revenue has seen impressive growth of 22.2% overall and 18.4% when excluding the impact of mergers and acquisitions, indicating strong core business performance. Furthermore, the recent increase in the net rate for the newly acquired Metro business, from $101 to $107.50, underscores the successful integration and value enhancement of its acquisitions.

Bears say

US Physical Therapy Inc has experienced a 0.6% decline in a key financial metric, decreasing from $84.46 to $83.95 compared to the same period last year. The company has faced ongoing reimbursement cuts over the past five years, cumulatively resulting in a $20 million reduction in profitability, which poses a significant risk to its financial stability. Additionally, operating expenses, including rent and clinic-related costs, rose to 20.2% of revenue, slightly above the projected 20.1%, indicating potential challenges in managing costs amidst fluctuating revenues.

USPH has been analyzed by 3 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 3 analysts, USPH has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.